SynthesisBlood advances2021

Current evidence on the efficacy and safety of generic imatinib in CML and the impact of generics on health care costs.

Abdülkadir Erçalışkan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.